Your browser doesn't support javascript.
loading
Awareness of patients receiving bisphosphonates: a cross-sectional study
LIMA-SOUZA, Reydson Alcides de; LEONEL, Augusto César Leal da Silva; DUARTE, Ângela Luzia Branco Pinto; CASTRO, Jurema Freire Lisboa de; CARVALHO, Elaine Judite de Amorim; PEREZ, Danyel Elias da Cruz.
  • LIMA-SOUZA, Reydson Alcides de; Universidade Estadual de Campinas. Piracicaba Dental School. Department of Oral Diagnosis. Piracicaba. BR
  • LEONEL, Augusto César Leal da Silva; Universidade Federal de Pernambuco. School of Dentistry. Department of Clinical and Preventive Dentistry. Recife. BR
  • DUARTE, Ângela Luzia Branco Pinto; Universidade Federal de Pernambuco. Hospital das Clínicas. Department of Rheumatology. Recife. BR
  • CASTRO, Jurema Freire Lisboa de; Universidade Federal de Pernambuco. School of Dentistry. Department of Clinical and Preventive Dentistry. Recife. BR
  • CARVALHO, Elaine Judite de Amorim; Universidade Federal de Pernambuco. School of Dentistry. Department of Clinical and Preventive Dentistry. Recife. BR
  • PEREZ, Danyel Elias da Cruz; Universidade Federal de Pernambuco. School of Dentistry. Department of Clinical and Preventive Dentistry. Recife. BR
Braz. oral res. (Online) ; 36: e0126, 2022. tab
Artigo em Inglês | LILACS-Express | LILACS, BBO | ID: biblio-1403952
ABSTRACT
Abstract The aim of this study was to evaluate the awareness of patients using bisphosphonates (BP) regarding their risks and benefits. Sixty-five patients using BP were included. Each participant completed a self-administered questionnaire consisting of 13 questions, including sociodemographic and general information on BP. Data were analyzed using descriptive statistics, and a binomial test was used to assess patient knowledge about BP, considering a 5% significance level. Fifty-nine (90.2%) patients were unaware or had never heard of BP drugs and only 3 (4.6%) knew their indications. Only 6 patients (9.2%) said they knew about the oral complications caused by BP. Sixty-three patients (96.9%) said they were not referred to the dentist before starting BP treatment. Patients using BP do not have satisfactory knowledge regarding the risks and benefits of BP. Physicians and dentists must be prepared to inform and counsel BP users about their adverse effects and possible risk factors. Our results emphasize the importance of public policies, whether individual or collective, to be taken to increase knowledge about BP to avoid medication-related osteonecrosis of the jaw.


Texto completo: DisponíveL Índice: LILACS (Américas) Tipo de estudo: Estudo observacional / Estudo de prevalência / Fatores de risco Idioma: Inglês Revista: Braz. oral res. (Online) Assunto da revista: Odontologia Ano de publicação: 2022 Tipo de documento: Artigo / Documento de projeto País de afiliação: Brasil Instituição/País de afiliação: Universidade Estadual de Campinas/BR / Universidade Federal de Pernambuco/BR

Similares

MEDLINE

...
LILACS

LIS


Texto completo: DisponíveL Índice: LILACS (Américas) Tipo de estudo: Estudo observacional / Estudo de prevalência / Fatores de risco Idioma: Inglês Revista: Braz. oral res. (Online) Assunto da revista: Odontologia Ano de publicação: 2022 Tipo de documento: Artigo / Documento de projeto País de afiliação: Brasil Instituição/País de afiliação: Universidade Estadual de Campinas/BR / Universidade Federal de Pernambuco/BR